Enterprise Value
1.553B
Cash
225.3M
Avg Qtr Burn
-14.42M
Short % of Float
5.28%
Insider Ownership
2.10%
Institutional Own.
-
Qtr Updated
09/30/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ARX788 Details Solid tumor/s, Cancer, Breast cancer | Phase 2 Data readout | |
ARX517 Details Solid tumor/s, Cancer, Prostate cancer | Phase 1/2 Data readout |